• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管哮喘作为一种心血管危险因素:一项前瞻性观察性研究。

Bronchial Asthma as a Cardiovascular Risk Factor: A Prospective Observational Study.

作者信息

Kreslová Marcela, Kirchnerová Olga, Rajdl Daniel, Sudová Vendula, Blažek Jiří, Sýkorová Aneta, Jehlička Petr, Trefil Ladislav, Schwarz Jan, Pomahačová Renata, Sýkora Josef

机构信息

Department of Paediatrics, Faculty Hospital, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 80, 30460 Pilsen, Czech Republic.

Department of Pneumology, Faculty Hospital, Faculty of Medicine in Pilsen, Charles University in Prague, E. Beneše 1128, 30100 Pilsen, Czech Republic.

出版信息

Biomedicines. 2022 Oct 18;10(10):2614. doi: 10.3390/biomedicines10102614.

DOI:10.3390/biomedicines10102614
PMID:36289876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9599703/
Abstract

Introduction: Asthma as a chronic inflammatory disorder has been suggested as a risk factor for endothelial dysfunction (ED), but studies on the association between asthma and cardiovascular disease (CVD) risk are limited. Background: We assessed associations of ED with the severity of asthma, eosinophilic inflammation, lung function, and asthma control. Methods: 52 young asthmatics (median age of 25.22 years) and 45 healthy individuals were included. Demographic, clinical, and laboratory findings were recorded. We evaluated microvascular responsiveness by recording the reactive hyperemia index (RHI) indicating post-occlusive peripheral endothelium-dependent changes in vascular tone using the Itamar Medical EndoPAT2000. VCAM-1, ADMA, high-sensitive CRP (hsCRP), and E-selectin were measured. Results: Asthmatics had considerably lower RHI values (p < 0.001) with a dynamic decreasing trend by asthma severity and higher hsCRP levels (p < 0.001). A substantial increase in hsCRP and E-selectin with asthma severity (p < 0.05) was also observed. We confirmed a higher body mass index (BMI) in asthmatics (p < 0.001), especially in women and in severe asthma. Conclusions: We demonstrated the progression of CVD in asthmatics and the association of the ongoing deterioration of ED with the inflammatory severity, suggesting that the increased risk of CVD in young asthmatics is dependent on disease severity. The underlying mechanisms of risk factors for CVD and disease control require further study.

摘要

引言

哮喘作为一种慢性炎症性疾病,已被认为是内皮功能障碍(ED)的一个危险因素,但关于哮喘与心血管疾病(CVD)风险之间关联的研究有限。背景:我们评估了内皮功能障碍与哮喘严重程度、嗜酸性粒细胞炎症、肺功能及哮喘控制之间的关联。方法:纳入52名年轻哮喘患者(中位年龄25.22岁)和45名健康个体。记录人口统计学、临床和实验室检查结果。我们使用Itamar Medical EndoPAT2000通过记录反应性充血指数(RHI)来评估微血管反应性,该指数表明闭塞后外周内皮依赖性血管张力变化。检测血管细胞黏附分子-1(VCAM-1)、不对称二甲基精氨酸(ADMA)、高敏C反应蛋白(hsCRP)和E-选择素。结果:哮喘患者的RHI值显著更低(p<0.001),且随哮喘严重程度呈动态下降趋势,hsCRP水平更高(p<0.001)。还观察到hsCRP和E-选择素随哮喘严重程度大幅增加(p<0.05)。我们证实哮喘患者的体重指数(BMI)更高(p<0.001),尤其是女性和重度哮喘患者。结论:我们证明了哮喘患者心血管疾病的进展以及内皮功能障碍持续恶化与炎症严重程度之间存在关联,这表明年轻哮喘患者心血管疾病风险增加取决于疾病严重程度。心血管疾病危险因素和疾病控制的潜在机制需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/9599703/4275246c217e/biomedicines-10-02614-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/9599703/adcfb598c808/biomedicines-10-02614-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/9599703/f19ddead0742/biomedicines-10-02614-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/9599703/4275246c217e/biomedicines-10-02614-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/9599703/adcfb598c808/biomedicines-10-02614-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/9599703/f19ddead0742/biomedicines-10-02614-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/9599703/4275246c217e/biomedicines-10-02614-g003.jpg

相似文献

1
Bronchial Asthma as a Cardiovascular Risk Factor: A Prospective Observational Study.支气管哮喘作为一种心血管危险因素:一项前瞻性观察性研究。
Biomedicines. 2022 Oct 18;10(10):2614. doi: 10.3390/biomedicines10102614.
2
Age-Related Progression of Microvascular Dysfunction in Cystic Fibrosis: New Detection Ways and Clinical Outcomes.囊性纤维化中与年龄相关的微血管功能障碍进展:新的检测方法和临床结果。
Physiol Res. 2021 Dec 30;70(6):893-903. doi: 10.33549/physiolres.934743. Epub 2021 Oct 30.
3
Circulating Serum Cystatin C as an Independent Risk Biomarker for Vascular Endothelial Dysfunction in Patients with COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Observational Study.循环血清胱抑素C作为儿童新冠病毒相关多系统炎症综合征(MIS-C)患者血管内皮功能障碍的独立风险生物标志物:一项前瞻性观察研究
Biomedicines. 2022 Nov 17;10(11):2956. doi: 10.3390/biomedicines10112956.
4
Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis.哮喘预示心血管疾病事件:动脉粥样硬化的多民族研究。
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1520-5. doi: 10.1161/ATVBAHA.115.305452. Epub 2015 Apr 23.
5
Plethysmographic and biochemical markers in the diagnosis of endothelial dysfunction in pediatric acute lymphoblastic leukemia survivors - new applications.体积描记法和生化标志物在儿童急性淋巴细胞白血病幸存者内皮功能障碍诊断中的应用——新应用
Physiol Res. 2018 Dec 18;67(6):903-909. doi: 10.33549/physiolres.933754. Epub 2018 Sep 11.
6
Endothelial Dysfunction Is Associated with Cerebrovascular Events in Pre-Dialysis CKD Patients: A Prospective Study.内皮功能障碍与透析前慢性肾脏病患者的脑血管事件相关:一项前瞻性研究。
Life (Basel). 2021 Feb 7;11(2):128. doi: 10.3390/life11020128.
7
Association of obstructive sleep apnea with microvascular endothelial dysfunction and subclinical coronary artery disease in a community-based population.社区人群中阻塞性睡眠呼吸暂停与微血管内皮功能障碍及亚临床冠状动脉疾病的相关性。
Vasc Med. 2018 Aug;23(4):331-339. doi: 10.1177/1358863X18755003. Epub 2018 Mar 14.
8
Reactive hyperaemia index as a marker of endothelial dysfunction in children with Crohn's disease is significantly lower than healthy controls.反应性充血指数作为克罗恩病患儿血管内皮功能障碍的标志物,显著低于健康对照组。
Acta Paediatr. 2014 Feb;103(2):e55-60. doi: 10.1111/apa.12467.
9
Measurement of Microvascular Function in Pediatric Inflammatory Bowel Disease.儿童炎症性肠病中小血管功能的测量。
J Pediatr Gastroenterol Nutr. 2019 May;68(5):662-668. doi: 10.1097/MPG.0000000000002252.
10
Advanced peripheral microvascular endothelial dysfunction and polyvascular disease in patients with high cardiovascular risk.心血管高危患者的晚期外周微血管内皮功能障碍和多血管疾病
J Cardiol. 2016 May;67(5):455-62. doi: 10.1016/j.jjcc.2015.07.003. Epub 2015 Sep 4.

引用本文的文献

1
Exploring the Mechanism of Bufei Decoction in the Treatment of Bronchial Asthma Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接技术探索补肺汤治疗支气管哮喘的作用机制
Comb Chem High Throughput Screen. 2025;28(5):768-780. doi: 10.2174/0113862073285566240223144925.
2
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences.哮喘与心血管疾病:共同药物相互作用的应对策略。
Drugs. 2024 Oct;84(10):1251-1273. doi: 10.1007/s40265-024-02086-5. Epub 2024 Sep 26.
3
Cardiovascular Events in Patients with Severe Asthma-A Retrospective Study of Two Cohorts: Asthma Type T2 Treated with Biologics and Non-Type T2.

本文引用的文献

1
Protective effect of inhaled corticosteroid on children with asthma with pneumonia.吸入性糖皮质激素对哮喘合并肺炎儿童的保护作用。
Front Pediatr. 2022 Aug 25;10:908857. doi: 10.3389/fped.2022.908857. eCollection 2022.
2
Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study.白三烯受体拮抗剂疗法能否改善接受生物疗法且并存支气管扩张的重度哮喘患者的病情控制?一项初步研究。
J Clin Med. 2022 Aug 11;11(16):4702. doi: 10.3390/jcm11164702.
3
Bronchial asthma and risk of 4 specific cardiovascular diseases and cardiovascular mortality: a meta-analysis of cohort studies.
重度哮喘患者的心血管事件——两个队列的回顾性研究:接受生物制剂治疗的T2型哮喘和非T2型哮喘
J Clin Med. 2024 Jul 23;13(15):4299. doi: 10.3390/jcm13154299.
4
E-selectin in vascular pathophysiology.血管病理生理学中的 E-选择素。
Front Immunol. 2024 Jul 19;15:1401399. doi: 10.3389/fimmu.2024.1401399. eCollection 2024.
5
High-intensity aerobic exercise training improves exercise capacity, dyspnea, and fatigue in patients with severe asthma using triple inhaler.高强度有氧运动训练可改善使用三联吸入器的重度哮喘患者的运动能力、呼吸困难和疲劳症状。
Tzu Chi Med J. 2024 Jan 12;36(1):76-82. doi: 10.4103/tcmj.tcmj_171_23. eCollection 2024 Jan-Mar.
6
Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies.内皮功能障碍、血小板活性亢进、高血压与代谢综合征:分子见解及应对策略。
Front Nutr. 2023 Aug 8;10:1221438. doi: 10.3389/fnut.2023.1221438. eCollection 2023.
7
Circulating Serum Cystatin C as an Independent Risk Biomarker for Vascular Endothelial Dysfunction in Patients with COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Observational Study.循环血清胱抑素C作为儿童新冠病毒相关多系统炎症综合征(MIS-C)患者血管内皮功能障碍的独立风险生物标志物:一项前瞻性观察研究
Biomedicines. 2022 Nov 17;10(11):2956. doi: 10.3390/biomedicines10112956.
支气管哮喘与 4 种特定心血管疾病及心血管死亡率的关系:队列研究的荟萃分析。
Eur Rev Med Pharmacol Sci. 2022 Jul;26(14):5081-5091. doi: 10.26355/eurrev_202207_29294.
4
Biological Therapy of Severe Asthma and Nasal Polyps.重度哮喘和鼻息肉的生物治疗
J Pers Med. 2022 Jun 16;12(6):976. doi: 10.3390/jpm12060976.
5
Age-Related Progression of Microvascular Dysfunction in Cystic Fibrosis: New Detection Ways and Clinical Outcomes.囊性纤维化中与年龄相关的微血管功能障碍进展:新的检测方法和临床结果。
Physiol Res. 2021 Dec 30;70(6):893-903. doi: 10.33549/physiolres.934743. Epub 2021 Oct 30.
6
Reversal of emphysema by restoration of pulmonary endothelial cells.肺内皮细胞修复逆转肺气肿。
J Exp Med. 2021 Aug 2;218(8). doi: 10.1084/jem.20200938. Epub 2021 Jul 21.
7
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study.美泊利珠单抗治疗伴有支扩的严重嗜酸性粒细胞性哮喘患者的有效性:一项真实世界回顾性研究。
Respir Med. 2021 Aug-Sep;185:106491. doi: 10.1016/j.rmed.2021.106491. Epub 2021 Jun 1.
8
Montelukast Use Decreases Cardiovascular Events in Asthmatics.孟鲁司特的使用可降低哮喘患者的心血管事件发生率。
Front Pharmacol. 2021 Jan 13;11:611561. doi: 10.3389/fphar.2020.611561. eCollection 2020.
9
Managing Asthma and Obesity Related Symptoms (MATADORS): An mHealth Intervention to Facilitate Symptom Self-Management among Youth.管理哮喘和肥胖相关症状(MATADORS):一种促进青少年症状自我管理的移动医疗干预措施。
Int J Environ Res Public Health. 2020 Oct 23;17(21):7750. doi: 10.3390/ijerph17217750.
10
Adults with current asthma but not former asthma have higher all-cause and cardiovascular mortality: a population-based prospective cohort study.当前患有哮喘而非既往患有哮喘的成年人全因死亡率和心血管死亡率更高:一项基于人群的前瞻性队列研究。
Sci Rep. 2021 Jan 14;11(1):1329. doi: 10.1038/s41598-020-79264-4.